RLAY
Price
$8.65
Change
+$0.34 (+4.09%)
Updated
Dec 24 closing price
Capitalization
1.5B
55 days until earnings call
Intraday BUY SELL Signals
RVMD
Price
$81.19
Change
+$0.92 (+1.15%)
Updated
Dec 24 closing price
Capitalization
15.7B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RLAY vs RVMD

Header iconRLAY vs RVMD Comparison
Open Charts RLAY vs RVMDBanner chart's image
Relay Therapeutics
Price$8.65
Change+$0.34 (+4.09%)
Volume$866.54K
Capitalization1.5B
Revolution Medicines
Price$81.19
Change+$0.92 (+1.15%)
Volume$1.4M
Capitalization15.7B
RLAY vs RVMD Comparison Chart in %
RLAY
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RLAY vs. RVMD commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Buy and RVMD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (RLAY: $8.65 vs. RVMD: $81.19)
Brand notoriety: RLAY and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 37% vs. RVMD: 58%
Market capitalization -- RLAY: $1.5B vs. RVMD: $15.7B
RLAY [@Biotechnology] is valued at $1.5B. RVMD’s [@Biotechnology] market capitalization is $15.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, both RLAY and RVMD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while RVMD’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • RVMD’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than RVMD.

Price Growth

RLAY (@Biotechnology) experienced а +7.72% price change this week, while RVMD (@Biotechnology) price change was +5.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 19, 2026.

RVMD is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($15.7B) has a higher market cap than RLAY($1.5B). RLAY YTD gains are higher at: 109.951 vs. RVMD (85.620). RLAY has higher annual earnings (EBITDA): -322.8M vs. RVMD (-1.02B). RVMD has more cash in the bank: 1.93B vs. RLAY (596M). RLAY has less debt than RVMD: RLAY (33.3M) vs RVMD (158M). RLAY has higher revenues than RVMD: RLAY (8.36M) vs RVMD (0).
RLAYRVMDRLAY / RVMD
Capitalization1.5B15.7B10%
EBITDA-322.8M-1.02B32%
Gain YTD109.95185.620128%
P/E RatioN/AN/A-
Revenue8.36M0-
Total Cash596M1.93B31%
Total Debt33.3M158M21%
FUNDAMENTALS RATINGS
RVMD: Fundamental Ratings
RVMD
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYRVMD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
66%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signal:
Gain/Loss:
RVMD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOFX35.270.68
+1.96%
Defiance Daily Target 2X Long SOFI ETF
BHYB54.510.14
+0.26%
Xtrackers USD High Yld BB-B ex Fin ETF
BAMB26.530.05
+0.18%
Brookstone Intermediate Bond ETF
BSMQ23.620.01
+0.04%
Invesco BulletShares 2026 Muncpl Bd ETF
KCAI30.31-0.05
-0.16%
KraneShares China Alpha Index ETF

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with BEAM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+4.09%
BEAM - RLAY
52%
Loosely correlated
+1.33%
NRIX - RLAY
52%
Loosely correlated
+0.36%
RVMD - RLAY
50%
Loosely correlated
+1.15%
KURA - RLAY
50%
Loosely correlated
+2.50%
CRNX - RLAY
50%
Loosely correlated
-0.33%
More

RVMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVMD has been loosely correlated with NUVL. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RVMD jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVMD
1D Price
Change %
RVMD100%
+1.15%
NUVL - RVMD
61%
Loosely correlated
+0.89%
CGON - RVMD
55%
Loosely correlated
+0.22%
CLDX - RVMD
54%
Loosely correlated
+0.94%
IDYA - RVMD
54%
Loosely correlated
+0.76%
IRON - RVMD
52%
Loosely correlated
+0.76%
More